These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2050996)

  • 21. Evidence that prostacyclin modulates the vascular actions of calcium in man.
    Nadler JL; McKay M; Campese V; Vrbanac J; Horton R
    J Clin Invest; 1986 Apr; 77(4):1278-84. PubMed ID: 3514678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of sulindac on prostaglandin excretion and renal function in cirrhotic patients with ascites.
    Guarner C; Enriquez J; Guarner F; Quiroga J; Just J; Seres I; Prieto J; Vilardell F
    Scand J Gastroenterol; 1986 Mar; 21(2):231-4. PubMed ID: 3715390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination.
    Guarner C; Soriano G; Such J; Teixidó M; Ramis I; Bulbena O; Roselló J; Guarner F; Gelpi E; Balanzó J
    Gastroenterology; 1992 Jan; 102(1):303-9. PubMed ID: 1727763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure.
    Liguori A; Casini A; Di Loreto M; Andreini I; Napoli C
    Eur J Clin Pharmacol; 1999 Apr; 55(2):117-24. PubMed ID: 10335906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of spironolactone on renal prostaglandin excretion in patients with liver cirrhosis and ascites.
    Medina JF; Prieto J; Guarner F; Quiroga J; Milazzo A
    J Hepatol; 1986; 3(2):206-11. PubMed ID: 3466948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin-independent protection by furosemide from oliguric ischemic renal failure in conscious rats.
    Kramer HJ; Schüürmann J; Wassermann C; Düsing R
    Kidney Int; 1980 Apr; 17(4):455-64. PubMed ID: 7392420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal hemodynamics and urinary excretion of 6-keto-prostaglandin F1 alpha and thromboxane B2 in newly diagnosed type I diabetic patients.
    Gambardella S; Andreani D; Cancelli A; Di Mario U; Cardamone I; Stirati G; Cinotti GA; Pugliese F
    Diabetes; 1988 Aug; 37(8):1044-8. PubMed ID: 3391343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin precursor fatty acids in cirrhosis with ascites: effect of linoleic acid infusion in functional renal failure.
    Rimola A; Ginés P; Cusó E; Camps J; Gaya J; Arroyo V; Rodés J
    Clin Sci (Lond); 1988 Jun; 74(6):613-9. PubMed ID: 3135142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study.
    Moutquin JM; Lindsay C; Arial N; De Grandpré P; C-Gaudreault R; Forest JC; Massé J
    Am J Obstet Gynecol; 1997 Dec; 177(6):1483-90. PubMed ID: 9423755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
    Stichtenoth DO; Marhauer V; Tsikas D; Gutzki FM; Frölich JC
    Kidney Int; 2005 Nov; 68(5):2197-207. PubMed ID: 16221219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of prostacyclin on renal kallikrein release in man.
    Pierucci A; Simonetti BM; Ciabattoni G; Taggi F; Morabito S; Vastano S; Pugliese F
    Eur J Clin Invest; 1986 Jun; 16(3):233-8. PubMed ID: 3089820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis.
    Assy N; Kayal M; Mejirisky Y; Gorenberg M; Hussein O; Schlesinger S
    BMC Gastroenterol; 2006 Nov; 6():39. PubMed ID: 17134488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
    Planas R; Arroyo V; Rimola A; Pérez-Ayuso RM; Rodés J
    Gastroenterology; 1983 Feb; 84(2):247-52. PubMed ID: 6401254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Furosemide increases urine 6-keto-prostaglandin F1 alpha. Relation to natriuresis, vasodilation, and renin release.
    Wilson TW; Loadholt CB; Privitera PJ; Halushka PV
    Hypertension; 1982; 4(5):634-41. PubMed ID: 7049918
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism.
    Nadler JL; Lee FO; Hsueh W; Horton R
    N Engl J Med; 1986 Apr; 314(16):1015-20. PubMed ID: 3515183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study.
    Laffi G; Marra F; Buzzelli G; Azzena G; Meacci E; De Feo ML; La Villa G; Gentilini P
    Hepatology; 1991 Jun; 13(6):1101-5. PubMed ID: 2050329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antihypertensive action of hydrochlorothiazide and renal prostacyclin.
    Wilson TW
    Clin Pharmacol Ther; 1986 Jan; 39(1):94-101. PubMed ID: 3510798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.